Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Mol Genet Metab. 2014 Jul 21;113(0):92–99. doi: 10.1016/j.ymgme.2014.07.008

Table 2.

Levels of ΔDiHS-0S and ΔDiHS-NS in patients with MPS III and control subjects over 3 years of age.

ΔDiHS-0S (ng/ml) ΔDiHS-NS (ng/ml)
Control 27.5 ± 8.7 22.7 ± 4.8
Untreated MPS IIIA 126.6 ± 30.0a 75.0 ± 11.5
Untreated MPS IIIB 161.3 ± 35.6a 95.0 ± 22.3a
HSCT treated MPS IIIB 43.6 40.5

Number of each group is as follows, Control (n = 59), untreated MPS IIIA (n = 6), untreated MPS IIIB (n = 11), and HSCT-treated MPS IIIB (n = 1)

a

significantly different from the control at p < 0.05